The lncRNA MIR2052HG regulates ERα levels and aromatase inhibitor resistance through LMTK3 by recruiting EGR1

Lignende værker

• Genetic polymorphisms in the long noncoding RNA MIR2052HG offer a pharmacogenomic basis for the response of breast cancer patients to aromatase inhibitor therapy
  af: Ingle, James N., et al.
  Udgivet: (2016)
• Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancer
  af: Ingle, James N., et al.
  Udgivet: (2019)
• Pharmacogenomics of aromatase inhibitors in postmenopausal breast cancer and additional mechanisms of anastrozole action
  af: Cairns, Junmei, et al.
  Udgivet: (2020)
• Estrogen, SNP-Dependent Chemokine Expression and Selective Estrogen Receptor Modulator Regulation
  af: Ho, Ming-Fen, et al.
  Udgivet: (2016)
• TCL1A Single-Nucleotide Polymorphisms and Estrogen-Mediated Toll-Like Receptor-MYD88–Dependent Nuclear Factor-κB Activation: Single-Nucleotide Polymorphism– and Selective Estrogen Receptor Modulator–Dependent Modification of Inflammation and Immune Response
  af: Ho, Ming-Fen, et al.
  Udgivet: (2017)